Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global In-vitro Colorectal Cancer Screening Tests Market 2021-2025

Published by TechNavio (Infiniti Research Ltd.) Product code 990069
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global In-vitro Colorectal Cancer Screening Tests Market 2021-2025
Published: February 12, 2021 Content info: 120 Pages
Description

Technavio has been monitoring the in-vitro colorectal cancer screening tests market and it is poised to grow by $ 270.96 mn during 2021-2025 progressing at a CAGR of 6% during the forecast period. Our report on in-vitro colorectal cancer screening tests market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising occurrence of colorectal cancer, growing awareness programs and government initiatives and presence of innovative products. In addition, rising occurrence of colorectal cancer is anticipated to boost the growth of the market as well.

The in-vitro colorectal cancer screening tests market analysis includes end-user segment and geographical landscapes.

Technavio's in-vitro colorectal cancer screening tests market is segmented as below:

By End-user

  • Hospitals
  • Clinical diagnostic laboratories
  • Others

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing importance of promotional and marketing activities as one of the prime reasons driving the in-vitro colorectal cancer screening tests market growth during the next few years. Also, increased product approvals and clinical trials and increased industry collaborations will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on in-vitro colorectal cancer screening tests market covers the following areas:

  • In-vitro colorectal cancer screening tests market sizing
  • In-vitro colorectal cancer screening tests market forecast
  • In-vitro colorectal cancer screening tests market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro colorectal cancer screening tests market vendors that include Abbott Laboratories, Danaher Corp., Epigenomics AG, Exact Sciences Corp., Immunostics Inc., NOVIGENIX SA, QIAGEN NV, Quest Diagnostics Inc., R-Biopharm AG, and Sysmex Corp.. Also, the in-vitro colorectal cancer screening tests market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR70201

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user
  • Hospitals - Market size and forecast 2020-2025
  • Clinical diagnostic laboratories - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by End user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Danaher Corp.
  • Epigenomics AG
  • Exact Sciences Corp.
  • Immunostics Inc.
  • NOVIGENIX SA
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • R-Biopharm AG
  • Sysmex Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: End user - Market share 2020-2025 (%)
  • 22: Comparison by End user
  • 23: Hospitals - Market size and forecast 2020-2025 ($ million)
  • 24: Hospitals - Year-over-year growth 2020-2025 (%)
  • 25: Clinical diagnostic laboratories - Market size and forecast 2020-2025 ($ million)
  • 26: Clinical diagnostic laboratories - Year-over-year growth 2020-2025 (%)
  • 27: Others - Market size and forecast 2020-2025 ($ million)
  • 28: Others - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by End user
  • 30: Customer landscape
  • 31: Market share by geography 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Abbott Laboratories - Overview
  • 50: Abbott Laboratories - Business segments
  • 51: Abbott Laboratories - Key offerings
  • 52: Abbott Laboratories - Key customers
  • 53: Abbott Laboratories - Segment focus
  • 54: Danaher Corp. - Overview
  • 55: Danaher Corp. - Business segments
  • 56: Danaher Corp. - Key offerings
  • 57: Danaher Corp. - Key customers
  • 58: Danaher Corp. - Segment focus
  • 59: Epigenomics AG - Overview
  • 60: Epigenomics AG - Business segments
  • 61: Epigenomics AG - Key offerings
  • 62: Epigenomics AG - Key customers
  • 63: Epigenomics AG - Segment focus
  • 64: Exact Sciences Corp. - Overview
  • 65: Exact Sciences Corp. - Business segments
  • 66: Exact Sciences Corp. - Key offerings
  • 67: Exact Sciences Corp. - Key customers
  • 68: Exact Sciences Corp. - Segment focus
  • 69: Immunostics Inc. - Overview
  • 70: Immunostics Inc. - Product and service
  • 71: Immunostics Inc. - Key offerings
  • 72: Immunostics Inc. - Key customers
  • 73: Immunostics Inc. - Segment focus
  • 74: NOVIGENIX SA - Overview
  • 75: NOVIGENIX SA - Product and service
  • 76: NOVIGENIX SA - Key offerings
  • 77: NOVIGENIX SA - Key customers
  • 78: NOVIGENIX SA - Segment focus
  • 79: QIAGEN NV - Overview
  • 80: QIAGEN NV - Business segments
  • 81: QIAGEN NV - Key offerings
  • 82: QIAGEN NV - Key customers
  • 83: QIAGEN NV - Segment focus
  • 84: Quest Diagnostics Inc. - Overview
  • 85: Quest Diagnostics Inc. - Business segments
  • 86: Quest Diagnostics Inc. - Key offerings
  • 87: Quest Diagnostics Inc. - Key customers
  • 88: Quest Diagnostics Inc. - Segment focus
  • 89: R-Biopharm AG - Overview
  • 90: R-Biopharm AG - Product and service
  • 91: R-Biopharm AG - Key offerings
  • 92: R-Biopharm AG - Key customers
  • 93: R-Biopharm AG - Segment focus
  • 94: Sysmex Corp. - Overview
  • 95: Sysmex Corp. - Business segments
  • 96: Sysmex Corp. - Key offerings
  • 97: Sysmex Corp. - Key customers
  • 98: Sysmex Corp. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations
Back to Top